Cargando…

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease

Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Chih-Jan, Gao, Shih-Ling, Lin, Tsu-Kung, Chu, Pei-Yi, Lin, Hung-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615560/
https://www.ncbi.nlm.nih.gov/pubmed/34829907
http://dx.doi.org/10.3390/biomedicines9111679
_version_ 1784604133943148544
author Ko, Chih-Jan
Gao, Shih-Ling
Lin, Tsu-Kung
Chu, Pei-Yi
Lin, Hung-Yu
author_facet Ko, Chih-Jan
Gao, Shih-Ling
Lin, Tsu-Kung
Chu, Pei-Yi
Lin, Hung-Yu
author_sort Ko, Chih-Jan
collection PubMed
description Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membrane rupture, release of damage-associated molecular patterns, and neuroinflammation. Due to the crucial role of intracellular iron in mediating the production of reactive oxygen species and the formation of lipid peroxides, ferroptosis is intimately controlled by regulators involved in many aspects of iron metabolism, including iron uptake, storage and export, and by pathways constituting the antioxidant systems. Translational and transcriptional regulation of iron homeostasis and redox status provide an integrated network to determine the sensitivity of ferroptosis. We herein review recent advances related to ferroptosis, ranging from fundamental mechanistic discoveries and cutting-edge preclinical animal studies, to clinical trials in PD and the regulation of neuroinflammation via ferroptosis pathways. Elucidating the roles of ferroptosis in the survival of dopaminergic neurons and microglial activity can enhance our understanding of the pathogenesis of PD and provide opportunities for the development of novel prevention and treatment strategies.
format Online
Article
Text
id pubmed-8615560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86155602021-11-26 Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease Ko, Chih-Jan Gao, Shih-Ling Lin, Tsu-Kung Chu, Pei-Yi Lin, Hung-Yu Biomedicines Review Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membrane rupture, release of damage-associated molecular patterns, and neuroinflammation. Due to the crucial role of intracellular iron in mediating the production of reactive oxygen species and the formation of lipid peroxides, ferroptosis is intimately controlled by regulators involved in many aspects of iron metabolism, including iron uptake, storage and export, and by pathways constituting the antioxidant systems. Translational and transcriptional regulation of iron homeostasis and redox status provide an integrated network to determine the sensitivity of ferroptosis. We herein review recent advances related to ferroptosis, ranging from fundamental mechanistic discoveries and cutting-edge preclinical animal studies, to clinical trials in PD and the regulation of neuroinflammation via ferroptosis pathways. Elucidating the roles of ferroptosis in the survival of dopaminergic neurons and microglial activity can enhance our understanding of the pathogenesis of PD and provide opportunities for the development of novel prevention and treatment strategies. MDPI 2021-11-12 /pmc/articles/PMC8615560/ /pubmed/34829907 http://dx.doi.org/10.3390/biomedicines9111679 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ko, Chih-Jan
Gao, Shih-Ling
Lin, Tsu-Kung
Chu, Pei-Yi
Lin, Hung-Yu
Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title_full Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title_fullStr Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title_full_unstemmed Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title_short Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
title_sort ferroptosis as a major factor and therapeutic target for neuroinflammation in parkinson’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615560/
https://www.ncbi.nlm.nih.gov/pubmed/34829907
http://dx.doi.org/10.3390/biomedicines9111679
work_keys_str_mv AT kochihjan ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease
AT gaoshihling ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease
AT lintsukung ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease
AT chupeiyi ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease
AT linhungyu ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease